Skip to main content
Year archive

Sanofi — 2019 filings

All 261 regulatory filings released by Sanofi (SAN) in 2019, sourced directly from the official regulator.

261 Filings
2019 Period
2019 filings (261)
Filing Released Lang
Regulatory Filings 2019
Regulatory Filings
2019-12-27 English
SC TO-T Filing
Regulatory Filings
2019-12-27 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, novembre 2019
Share Issue/Capital Change
2019-12-23 French
Sanofi: information concerning the total number of voting rights and shares, November 2019
Declaration of Voting Results & Voting Rights Announcements
2019-12-23 English
Sanofi lance l’offre publique d’achat en vue de l’acquisition de Synthorx, Inc.
M&A Activity
2019-12-23 French
Sanofi commences tender offer for acquisition of Synthorx, Inc.
M&A Activity
2019-12-23 English
Regulatory Filings 2019
Regulatory Filings
2019-12-20 English
6-K
Foreign Filer Report
2019-12-11 English
SC TO-C Filing
Regulatory Filings
2019-12-11 English
6-K
Foreign Filer Report
2019-12-10 English
Sanofi et Regeneron annoncent leur intention de restructurer leur accord de collaboration sur les anticorps concernant Kevzara® (sarilumab) et Praluent® (alirocumab)
M&A Activity
2019-12-10 French
Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)
M&A Activity
2019-12-10 English
Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease
Regulatory Filings
2019-12-10 English
Sanofi : Présentation des résultats positifs d’un essai pivot de phase III du sutimlimab dans le traitement de la maladie des agglutinines froides
Investor Presentation
2019-12-10 French
SC TO-C Filing
Regulatory Filings
2019-12-10 English
FORM 6-K
Foreign Filer Report
2019-12-09 English
Le Directeur Général de Sanofi dévoile sa stratégie pour dynamiser l’innovation et la croissance de l’entreprise
Investor Presentation
2019-12-09 French
Sanofi CEO unveils new strategy to drive innovation and growth
Investor Presentation
2019-12-09 English
Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
M&A Activity
2019-12-09 English
Sanofi : Sanofi va acquérir Synthorx pour 2,5 milliards de dollars et renforcer son portefeuille en immuno-oncologie
M&A Activity
2019-12-09 French
SC TO-C Filing
Regulatory Filings
2019-12-09 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, octobre 2019
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 French
Sanofi: information concerning the total number of voting rights and shares, October 2019
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
Sanofi : Résultats positifs de phase III pour Toujeo® dans le traitement du diabète de type 1 de l’enfant et de l’adolescent
Earnings Release FY 2019
2019-11-04 French
Sanofi : Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
Regulatory Filings
2019-11-04 English
6-K
Foreign Filer Report
2019-10-31 English
6-K
Foreign Filer Report
2019-10-31 English
Troisième trimestre bien orienté pour Sanofi
Earnings Release Q3 2019
2019-10-31 French
Sanofi Q3 well on track
Interim / Quarterly Report Q3 2019
2019-10-31 English
Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation
Legal Proceedings Report
2019-10-31 English
Sanofi : Dupixent® (dupilumab) désormais approuvé dans l’Union européenne pour le traitement de la polypose nasosinusienne sévère
Regulatory Filings
2019-10-29 French
Sanofi : Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis
Regulatory Filings
2019-10-29 English
Sanofi: information concerning the total number of voting rights and shares, September 2019
Share Issue/Capital Change
2019-10-21 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, septembre 2019
Share Issue/Capital Change
2019-10-21 French
Sanofi: information concerning the total number of voting rights and shares, September 2019
Share Issue/Capital Change
2019-10-21 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, septembre 2019
Share Issue/Capital Change
2019-10-21 French
Sanofi: information concerning the total number of voting rights and shares, September 2019
Declaration of Voting Results & Voting Rights Announcements
2019-10-21 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, septembre 2019
Regulatory Filings
2019-10-21 French
FORM 6-K
Foreign Filer Report
2019-10-15 English
Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing
Regulatory Filings
2019-10-15 English
Sanofi inaugure sa première usine digitale de fabrication en continu et ouvre la voie à la prochaine génération de sites de production de biomédicaments      
Regulatory Filings
2019-10-15 French
Sanofi inaugure sa première usine digitale de fabrication en continu et ouvre la voie à la prochaine génération de sites de production de biomédicaments      
Regulatory Filings
2019-10-15 French
Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing
Regulatory Filings
2019-10-15 English
Sanofi inaugure sa première usine digitale de fabrication en continu et ouvre la voie à la prochaine génération de sites de production de biomédicaments
Regulatory Filings
2019-10-15 French
Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing
Regulatory Filings
2019-10-15 English
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
Report Publication Announcement
2019-10-01 French
Sanofi : Availability of the Pre-quarterly Results Communication
Report Publication Announcement
2019-10-01 English
Sanofi : Availability of the Pre-quarterly Results Communication
Report Publication Announcement
2019-10-01 English
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
Report Publication Announcement
2019-10-01 French
Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate c
Regulatory Filings
2019-09-30 English
Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne d
Regulatory Filings
2019-09-30 French
Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate c
Regulatory Filings
2019-09-30 English
Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne d
Regulatory Filings
2019-09-30 French
Franchissement de seuil
Major Shareholding Notification
2019-09-25 French
Franchissement de seuil
Major Shareholding Notification
2019-09-24 French
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère  
Regulatory Filings
2019-09-20 French
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère  
Regulatory Filings
2019-09-20 French
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  
Regulatory Filings
2019-09-20 English
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  
Regulatory Filings
2019-09-20 English
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère  
Regulatory Filings
2019-09-20 French
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  
Regulatory Filings
2019-09-20 English
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère  
Regulatory Filings
2019-09-20 French
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  
Regulatory Filings
2019-09-20 English
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère  
Regulatory Filings
2019-09-20 French
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère  
Regulatory Filings
2019-09-20 French
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  
Regulatory Filings
2019-09-20 English
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  
Regulatory Filings
2019-09-20 English
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis
Regulatory Filings
2019-09-20 English
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère
Regulatory Filings
2019-09-20 French
Franchissement de seuil
Major Shareholding Notification
2019-09-19 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Share Issue/Capital Change
2019-09-16 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Share Issue/Capital Change
2019-09-16 French
Sanofi: information concerning the total number of voting rights and shares, August 2019
Share Issue/Capital Change
2019-09-16 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Regulatory Filings
2019-09-16 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Regulatory Filings
2019-09-16 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Share Issue/Capital Change
2019-09-16 French
Sanofi: information concerning the total number of voting rights and shares, August 2019
Share Issue/Capital Change
2019-09-16 English
Sanofi: information concerning the total number of voting rights and shares, August 2019
Share Issue/Capital Change
2019-09-16 English
Sanofi: information concerning the total number of voting rights and shares, August 2019
Share Issue/Capital Change
2019-09-16 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Regulatory Filings
2019-09-16 French
Sanofi: information concerning the total number of voting rights and shares, August 2019
Share Issue/Capital Change
2019-09-16 English
Sanofi: information concerning the total number of voting rights and shares, August 2019
Declaration of Voting Results & Voting Rights Announcements
2019-09-16 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
Declaration of Voting Results & Voting Rights Announcements
2019-09-16 French
Sanofi: information concerning the total number of voting rights and shares, August 2019
Declaration of Voting Results & Voting Rights Announcements
2019-09-16 English
Sanofi et Abbott s’associent pour intégrer les technologies de mesure de la glycémie et d’administration d’insuline afin de transformer la prise en charge du diabète
Regulatory Filings
2019-09-16 French
Sanofi et Abbott s’associent pour intégrer les technologies de mesure de la glycémie et d’administration d’insuline afin de transformer la prise en charge du diabète
Regulatory Filings
2019-09-16 French
Sanofi et Abbott s’associent pour intégrer les technologies de mesure de la glycémie et d’administration d’insuline afin de transformer la prise en charge du diabète
Regulatory Filings
2019-09-16 French
Sanofi et Abbott s’associent pour intégrer les technologies de mesure de la glycémie et d’administration d’insuline afin de transformer la prise en charge du diabète
Regulatory Filings
2019-09-16 French
Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed
Regulatory Filings
2019-09-16 English
Franchissement de seuil
Major Shareholding Notification
2019-09-12 French
Franchissement de seuil
Major Shareholding Notification
2019-09-09 French
6-K
Foreign Filer Report
2019-09-03 English
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Regulatory Filings
2019-08-28 English
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Report Publication Announcement
2019-08-28 English
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Regulatory Filings
2019-08-28 English
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Regulatory Filings
2019-08-28 English
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Legal Proceedings Report
2019-08-28 French
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Legal Proceedings Report
2019-08-28 French
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Legal Proceedings Report
2019-08-28 French
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Regulatory Filings
2019-08-28 French
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Regulatory Filings
2019-08-28 French
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Report Publication Announcement
2019-08-28 English
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Regulatory Filings
2019-08-28 English
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Regulatory Filings
2019-08-28 French
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
Legal Proceedings Report
2019-08-28 French
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
Legal Proceedings Report
2019-08-28 English
Franchissement de seuil
Major Shareholding Notification
2019-08-28 French
Franchissement de seuil
Major Shareholding Notification
2019-08-22 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Share Issue/Capital Change
2019-08-19 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Regulatory Filings
2019-08-19 French
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Share Issue/Capital Change
2019-08-19 French
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Share Issue/Capital Change
2019-08-19 French
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Regulatory Filings
2019-08-19 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Share Issue/Capital Change
2019-08-19 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Share Issue/Capital Change
2019-08-19 French
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi: information concerning the total number of voting rights and shares, July 2019
Share Issue/Capital Change
2019-08-19 English
Sanofi: information concerning the total number of voting rights and shares, July 2019
Regulatory Filings
2019-08-19 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
Share Issue/Capital Change
2019-08-19 French
6-K
Foreign Filer Report
2019-08-09 English
Franchissement de seuil
Major Shareholding Notification
2019-08-09 French
Franchissement de seuil
Major Shareholding Notification
2019-08-06 French
Sanofi : Dupixent® (dupilumab) a montré des résultats de phase III positifs dans le traitement de la dermatite atopique sévère de l’enfant âgé de 6 à 11 ans
Earnings Release Q4 2019
2019-08-06 French
Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis
Regulatory Filings
2019-08-06 English
Sanofi : Dupixent® (dupilumab) approuvé par la Commission européenne pour traiter la dermatite atopique modérée à sévère chez les adolescents
Regulatory Filings
2019-08-06 French
Sanofi : Dupixent® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis
Regulatory Filings
2019-08-06 English
6-K
Foreign Filer Report
2019-07-29 English
Sanofi : Online Availability of Sanofi Group’s Half-Year Financial Report for 2019
Report Publication Announcement
2019-07-29 English
Sanofi : Mise en ligne du rapport financier semestriel 2019
Report Publication Announcement
2019-07-29 French
Sanofi : Rapport Financier Semestriel 2019
Interim / Quarterly Report H2 2019
2019-07-29 French
6-K
Foreign Filer Report
2019-07-29 English
SC 13G
Major Shareholding Notification
2019-07-29 English
Sanofi affiche une croissance solide au deuxième trimestre 2019
Earnings Release Q2 2019
2019-07-29 French
Sanofi delivered solid growth in Q2 2019
Interim / Quarterly Report Q2 2019
2019-07-29 English
Sanofi :  Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon
Legal Proceedings Report
2019-07-26 English
Sanofi : Sanofi fournit des informations actualisées sur ZynquistaTM (sotagliflozine) dans le traitement du diabète de type 2 et sa collaboration avec Lexicon
Regulatory Filings
2019-07-26 French
Sanofi : Information on the departure conditions of Olivier Brandicourt, Chief Executive Officer
Remuneration Information
2019-07-26 English
Sanofi : Information sur les conditions de départ d’Olivier Brandicourt, Directeur Général
Remuneration Information
2019-07-26 French
6-K
Foreign Filer Report
2019-07-26 English
FORM 4 SUBMISSION
Director's Dealing
2019-07-23 English
FORM 3 SUBMISSION
Director's Dealing
2019-07-18 English
FORM 6-K
Foreign Filer Report
2019-07-16 English
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juin 2019
Declaration of Voting Results & Voting Rights Announcements
2019-07-15 French
Sanofi: information concerning the total number of voting rights and shares, June 2019
Declaration of Voting Results & Voting Rights Announcements
2019-07-15 English
Sanofi : La FDA va examiner la demande d’approbation de l’isatuximab dans le traitement potentiel du myélome multiple réfractaire ou en rechute
Regulatory Filings
2019-07-10 French
Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma
Regulatory Filings
2019-07-10 English
Franchissement de seuil
Major Shareholding Notification
2019-07-05 French
Franchissement de seuil
Major Shareholding Notification
2019-07-04 French
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
Report Publication Announcement
2019-07-02 French
Sanofi : Availability of the Pre-quarterly Results Communication
Report Publication Announcement
2019-07-02 English
Sanofi : Libtayo® (cemiplimab) approuvé dans l’Union européenne pour le traitement du carcinome épidermoïde cutané au stade avancé
Regulatory Filings
2019-07-01 French
Sanofi : Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union
Regulatory Filings
2019-07-01 English
11-K
Regulatory Filings
2019-06-28 English
11-K
Regulatory Filings
2019-06-28 English
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère de l’adolescent
Regulatory Filings
2019-06-28 French
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents
Regulatory Filings
2019-06-28 English
Sanofi : La FDA va examiner le dossier du candidat-vaccin méningococcique MenQuadfi
Regulatory Filings
2019-06-27 French
Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate
Regulatory Filings
2019-06-27 English
Sanofi : La FDA approuve Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne
Regulatory Filings
2019-06-26 French
Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis
Regulatory Filings
2019-06-26 English
Sanofi et Regeneron annoncent les premiers résultats positifs de phase II de leur anticorps anti-IL-33 dans le traitement de l’asthme
Regulatory Filings
2019-06-21 French
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma
Earnings Release FY 2019
2019-06-21 English
6-K
Foreign Filer Report
2019-06-18 English
Sanofi and Google to develop new healthcare Innovation Lab
Regulatory Filings
2019-06-18 English
Sanofi et Google vont développer un nouveau laboratoire d’innovation en santé
Regulatory Filings
2019-06-18 French
Sanofi : informations relatives au nombre total de droits de vote et d’actions, mai 2019
Notice of Dividend Amount
2019-06-17 French
Sanofi: information concerning the total number of voting rights and shares, May 2019
Share Issue/Capital Change
2019-06-17 English
Communiqué de presse
Regulatory Filings
2019-06-09 French
Press Release
Earnings Release Q2 2019
2019-06-09 English
6-K
Foreign Filer Report
2019-06-07 English
Press Release
Board/Management Information
2019-06-07 English
Communiqué de presse
Board/Management Information
2019-06-07 French
6-K
Foreign Filer Report
2019-06-05 English
Communiqué de presse (PDF)
Investor Presentation
2019-06-02 French
Press release (PDF)
Regulatory Filings
2019-06-02 English
Franchissement de seuils
Major Shareholding Notification
2019-05-23 French
SD
Regulatory Filings
2019-05-22 English
Press Release
Declaration of Voting Results & Voting Rights Announcements
2019-05-21 English
Communiqué de presse
Declaration of Voting Results & Voting Rights Announcements
2019-05-21 French
Franchissement de seuil
Major Shareholding Notification
2019-05-17 French
Franchissement de seuils
Major Shareholding Notification
2019-05-14 French
Press release (PDF)
Regulatory Filings
2019-05-07 English
Communiqué de presse (PDF)
Regulatory Filings
2019-05-07 French
SC 13G/A
Major Shareholding Notification
2019-05-03 English
Press release (pdf)
AGM Information
2019-04-30 English
Communiqué de presse (pdf)
AGM Information
2019-04-30 French
6-K
Foreign Filer Report
2019-04-29 English
Press release (PDF)
Regulatory Filings
2019-04-27 English
Communiqué de presse (PDF)
Regulatory Filings
2019-04-27 French
Press release (PDF)
Regulatory Filings
2019-04-26 English
Communiqué de presse (PDF)
Regulatory Filings
2019-04-26 French
Press release (PDF)
Earnings Release FY 2019
2019-04-26 English
Communiqué de presse (PDF)
Legal Proceedings Report
2019-04-26 French
T1 2019 Résultats
Earnings Release Q1 2019
2019-04-26 French
Q1 2019 Results
Earnings Release Q1 2019
2019-04-26 English
Reporting EN
Declaration of Voting Results & Voting Rights Announcements
2019-04-12 English
Reporting FR
Declaration of Voting Results & Voting Rights Announcements
2019-04-12 French
Reporting FR
Transaction in Own Shares
2019-04-10 English
Reporting EN
Transaction in Own Shares
2019-04-10 English
Franchissement de seuil
Major Shareholding Notification
2019-04-08 French
Press release (PDF)
Regulatory Filings
2019-04-08 English
Communiqué de presse (PDF)
Regulatory Filings
2019-04-08 French
Franchissement de seuil
Major Shareholding Notification
2019-04-05 French
Communiqué de presse (PDF)
Report Publication Announcement
2019-04-01 French
Press release (PDF)
Report Publication Announcement
2019-04-01 English
Reporting EN
Declaration of Voting Results & Voting Rights Announcements
2019-03-25 English
Reporting FR
Declaration of Voting Results & Voting Rights Announcements
2019-03-25 French
Press release (PDF)
Regulatory Filings
2019-03-22 English
Communiqué de presse (PDF)
Regulatory Filings
2019-03-22 French
SANOFI MARCH 2034 NOTES FINAL TERMS
Capital/Financing Update
2019-03-19 English
FORM 6-K
Foreign Filer Report
2019-03-19 English
Communiqué de presse (PDF)
Regulatory Filings
2019-03-15 French
Press release (PDF)
Regulatory Filings
2019-03-15 English
Communiqué de presse (pdf)
Report Publication Announcement
2019-03-08 French
Press release (pdf)
Report Publication Announcement
2019-03-08 English
IRANNOTICE
Regulatory Filings
2019-03-08 English
20-F
Annual Report FY 2018
2019-03-08 English
Press release (pdf)
Regulatory Filings
2019-03-08 English
Communiqué de presse (pdf)
Regulatory Filings
2019-03-08 French
2018 20-F
Annual Report FY 2018
2019-03-08 English
Communiqué de presse (PDF)
Regulatory Filings
2019-03-01 French
Press Release (PDF)
Regulatory Filings
2019-03-01 English
Communiqué de presse (PDF)
Regulatory Filings
2019-03-01 French
Press release (PDF)
Regulatory Filings
2019-03-01 English
FORM 6-K
Foreign Filer Report
2019-02-26 English
PDF
Legal Proceedings Report
2019-02-25 French
Communiqué de presse (pdf)
Investor Presentation
2019-02-25 French
Press release (pdf)
Regulatory Filings
2019-02-25 English
SC 13G/A
Major Shareholding Notification
2019-02-15 English
FORM 4 SUBMISSION
Director's Dealing
2019-02-15 English
SC 13G/A
Major Shareholding Notification
2019-02-12 English
Reporting EN
Regulatory Filings
2019-02-12 English
Reporting FR
Share Issue/Capital Change
2019-02-12 French
Communiqué de presse (pdf)
Board/Management Information
2019-02-12 French
Press release (pdf)
Board/Management Information
2019-02-12 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-11 English
SC 13G/A
Major Shareholding Notification
2019-02-11 English
SC 13G/A
Major Shareholding Notification
2019-02-11 English
SC 13G
Major Shareholding Notification
2019-02-11 English
6-K
Foreign Filer Report
2019-02-07 English
Communiqué de presse (PDF)
Board/Management Information
2019-02-06 French
Press release (PDF)
Board/Management Information
2019-02-06 English
6-K
Foreign Filer Report
2019-02-04 English
Communiqué de presse (PDF)
Earnings Release FY 2019
2019-01-30 French
Press Release
Regulatory Filings
2019-01-30 English
FORM 4 SUBMISSION
Director's Dealing
2019-01-22 English
Press release (PDF)
Legal Proceedings Report
2019-01-18 English
Communiqué de presse (PDF)
Regulatory Filings
2019-01-18 French
Reporting FR
Share Issue/Capital Change
2019-01-15 French
Reporting EN
Regulatory Filings
2019-01-15 English
Press release (PDF)
Report Publication Announcement
2019-01-11 English
Communiqué de presse (PDF)
Regulatory Filings
2019-01-09 French
Press release (PDF)
Regulatory Filings
2019-01-09 English
6-K
Foreign Filer Report
2019-01-07 English
Communiqué de presse
M&A Activity
2019-01-07 French
Press Release
Regulatory Filings
2019-01-07 English